The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...

Abbott Laboratories (ABT) stock has drifted slightly lower this month, with shares showing a 7% drop over the past month.

The stock's fall snapped a two-day winning streak.

Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...

Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott ...

Q3 2025 Earnings Call Transcript October 15, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS ...

Abbott’s strong Q3, global diversification, and resilient portfolio support long-term growth despite diagnostics softness and ...

Abbott Laboratories closed 10.54% short of its 52-week high of $141.23, which the company achieved on March 4th.

Abbott Laboratories (ABT) stock drops as the company's Q3 2025 results miss revenue estimates as diagnostics unit contracts ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

According to a filing with the Securities and Exchange Commission dated October 14, 2025, CCLA Investment Management ...

Fintel reports that on October 17, 2025, Barclays maintained coverage of Abbott Laboratories (NYSE:ABT) with a Overweight ...